$363 Million is the total value of Integral Health Asset Management, LLC's 71 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | New | BIOGEN INC | $12,119,000 | – | 35,000 | +100.0% | 3.34% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $10,333,000 | – | 18,500 | +100.0% | 2.84% | – |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $9,518,000 | – | 65,000 | +100.0% | 2.62% | – |
| SNY | New | SANOFIsponsored adr | $9,216,000 | – | 175,000 | +100.0% | 2.54% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $8,014,000 | – | 70,000 | +100.0% | 2.21% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $6,732,000 | – | 65,000 | +100.0% | 1.85% | – |
| A | New | AGILENT TECHNOLOGIES INC | $5,912,000 | – | 40,000 | +100.0% | 1.63% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $4,579,000 | – | 475,000 | +100.0% | 1.26% | – |
| AGL | New | AGILON HEALTH INC | $4,057,000 | – | 100,000 | +100.0% | 1.12% | – |
| BNTX | New | BIONTECH SEsponsored ads | $3,806,000 | – | 17,000 | +100.0% | 1.05% | – |
| ALKS | New | ALKERMES PLC | $3,678,000 | – | 150,000 | +100.0% | 1.01% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $3,318,000 | – | 50,000 | +100.0% | 0.91% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $3,073,000 | – | 175,000 | +100.0% | 0.85% | – |
| SIBN | New | SI-BONE INC | $2,832,000 | – | 90,000 | +100.0% | 0.78% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $2,212,000 | – | 35,000 | +100.0% | 0.61% | – |
| DTIL | New | PRECISION BIOSCIENCES INC | $2,191,000 | – | 175,000 | +100.0% | 0.60% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $2,002,000 | – | 5,000 | +100.0% | 0.55% | – |
| MCRB | New | SERES THERAPEUTICS INC | $1,789,000 | – | 75,000 | +100.0% | 0.49% | – |
| ONEM | New | 1LIFE HEALTHCARE INC | $1,653,000 | – | 50,000 | +100.0% | 0.46% | – |
| ALT | New | ALTIMMUNE INC | $1,576,000 | – | 160,000 | +100.0% | 0.43% | – |
| HRTX | New | HERON THERAPEUTICS INC | $1,552,000 | – | 100,000 | +100.0% | 0.43% | – |
| AXGN | New | AXOGEN INC | $1,513,000 | – | 70,000 | +100.0% | 0.42% | – |
| New | TRILLIUM THERAPEUTICS INC | $1,455,000 | – | 150,000 | +100.0% | 0.40% | – | |
| FMTX | New | FORMA THERAPEUTICS HLDGS INC | $1,120,000 | – | 45,000 | +100.0% | 0.31% | – |
| CMRX | New | CHIMERIX INC | $600,000 | – | 75,000 | +100.0% | 0.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-08-30
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.